8 November 2017 | Geneva –– The World Health Organization (WHO) and the Mundo Sano Foundation are working together to make an essential antiparasitic medicine for the treatment of Chagas disease widely accessible to children.
Treatment with benznidazole in the early stages of infection can cure Chagas disease.
Unfortunately, few people are currently able to access diagnosis and treatment services.
Chagas disease (American trypanosomiasis)
Screening for Chagas in Colombia, 2010
Chagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite, Trypanosoma cruzi or (T. cruzi).
Once confined to the Region of the Americas, Chagas disease has spread to other continents over the last century due to increased travel and global population movement.
More than 10 000 people die every year from clinical manifestations of Chagas disease, and an estimated 25 million people risk acquiring the disease.
Curso de capacitação dos microscopistas de malária e dos laboratoristas da rede pública na detecção do Trypanosoma cruzi
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis: WHO TRS N°975
Evaluation of two International Reference Standards for antibodies to Trypanosoma cruzi in a WHO collaborative study
Kissing Bugs –"Triatomines - Vector of disease ": Chagas disease vector
Learn about the disease
Animated life cycle of T. cruzi in the human host
+41 22 791 1637
+41 79 540 50 86 (mobile)